Bruce Jackson
Stock Analyst at Benchmark Co.
(0.09)
# 4,676
Out of 4,988 analysts
304
Total ratings
37.2%
Success rate
-8.8%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics | Reiterated: Buy | $13 → $15 | $4.80 | +212.50% | 12 | Aug 20, 2026 | |
| PODD Insulet | Reiterated: Buy | $250 → $185 | $140.60 | +31.58% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $77 → $82 | $89.35 | -8.23% | 2 | Jul 31, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $11 → $16 | $19.91 | -19.64% | 24 | Jul 24, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $20 | $21.79 | -8.21% | 2 | Jun 3, 2026 | |
| HUMA Humacyte | Reiterated: Buy | $1 → $2 | $0.5856 | +241.53% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Reiterated: Buy | $3 | $1.32 | +127.27% | 20 | May 19, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $16.87 | - | 1 | May 11, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $120 | $102.61 | +16.95% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Reiterated: Buy | $14 → $10 | $6.70 | +49.25% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $20 | $2.53 | +690.51% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $6 | $7.96 | -24.62% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $187 → $217 | $170.96 | +26.93% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $4.35 | +612.64% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.25 → $1 | $0.4075 | +145.40% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.675 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $140 | $0.48 | n/a | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.26 | n/a | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $11.01 | n/a | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.20 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.79 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.35 → $2 | $2.01 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $24 | $4.08 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.507 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $0.4 | $0.000001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $960 → $240 | $0.0001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $20.82 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $4.03 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.98 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $5.20 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.59 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.11 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.28 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.3097 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $44.23 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.77 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.03 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $15.22 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $92.13 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $43.34 | n/a | 2 | Mar 2, 2012 |
Unicycive Therapeutics
Aug 20, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $4.80
Upside: +212.50%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $250 → $185
Current: $140.60
Upside: +31.58%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $77 → $82
Current: $89.35
Upside: -8.23%
NeoGenomics
Jul 24, 2026
Reiterated: Buy
Price Target: $11 → $16
Current: $19.91
Upside: -19.64%
MiniMed Group
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $21.79
Upside: -8.21%
Humacyte
Jun 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.5856
Upside: +241.53%
Biofrontera
May 19, 2026
Reiterated: Buy
Price Target: $3
Current: $1.32
Upside: +127.27%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $16.87
Upside: -
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $120
Current: $102.61
Upside: +16.95%
CapsoVision
Mar 27, 2026
Reiterated: Buy
Price Target: $14 → $10
Current: $6.70
Upside: +49.25%
Mar 20, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $2.53
Upside: +690.51%
Mar 16, 2026
Reiterated: Buy
Price Target: $20 → $6
Current: $7.96
Upside: -24.62%
Mar 3, 2026
Reiterated: Buy
Price Target: $187 → $217
Current: $170.96
Upside: +26.93%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $4.35
Upside: +612.64%
Nov 20, 2025
Reiterated: Buy
Price Target: $1.25 → $1
Current: $0.4075
Upside: +145.40%
Nov 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.675
Upside: -
Sep 15, 2025
Reiterated: Buy
Price Target: $280 → $140
Current: $0.48
Upside: n/a
Sep 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.26
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $30
Current: $11.01
Upside: n/a
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $2.20
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.79
Upside: n/a
Jun 6, 2024
Reiterated: Buy
Price Target: $1.35 → $2
Current: $2.01
Upside: n/a
Apr 15, 2024
Reiterated: Buy
Price Target: $40 → $24
Current: $4.08
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.507
Upside: n/a
Mar 22, 2024
Reiterated: Buy
Price Target: $4 → $0.4
Current: $0.000001
Upside: n/a
Sep 21, 2023
Reiterated: Buy
Price Target: $960 → $240
Current: $0.0001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $20.82
Upside: n/a
Aug 24, 2023
Reiterated: Buy
Price Target: $9 → $5
Current: $4.03
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $0.98
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $8 → $4
Current: $5.20
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.59
Upside: n/a
Jun 29, 2021
Reiterated: Buy
Price Target: $8
Current: $5.11
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.28
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.3097
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $44.23
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.77
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $1.03
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $15.22
Upside: n/a
Nov 21, 2012
Reiterated: Hold
Price Target: $46
Current: $92.13
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $43.34
Upside: n/a